Phase 2 study of everolimus for relapsed or refractory classical Hodgkin lymphoma. [electronic resource]
Publication details: Experimental hematology & oncology 2018Description: 12 p. digitalISSN:- 2162-3619
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.